ArticleAnnals of translational medicine2020

Is pembrolizumab monotherapy the optimal treatment for elderly patients with PD-L1 positive advanced non-small cell lung cancer?

Fiona Mienko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.